UK Government commits to funding EU research projects after Brexit
August 15, 2016Manufacturing and Production, Research and Development brexit, research
Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …
Top ten stories in the pharmaceutical industry this week
August 15, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10
It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
Acute coronary syndrome market to grow to over $12 billion by 2022
August 15, 2016Research and Development, Sales and Marketing GlobalData, acute coronary syndrome
The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …
Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug
August 15, 2016Sales and Marketing Endo, Endo International, abuse deterrent, opioid
Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
Novartis invests €100 million to expand French manufacturing plant
August 15, 2016Manufacturing and Production, Sales and Marketing Novartis, manufacturing
Novartis has sealed the deal with construction firm Jacobs Engineering group to expand production operations at its France Center of …
Sanofi launches dengue immunisation program in Brazil
August 15, 2016Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines
Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
Study shows promise for Venclexta in acute myelogenous leukaemia
August 12, 2016Research and Development, Sales and Marketing AbbVie, Genentech, Roche, Venclexta, venetoclax
A study published in Cancer Discovery, the journal of the American Association for Cancer Research, suggests that Vencletxa (venetoclax) is …
Promising results for new type 2 diabetes management procedure
August 12, 2016Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes
Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …
Ashfield publishes a guide to Patient Support Programmes: Ten steps to success
August 12, 2016Medical Communications, Research and Development, Sales and Marketing
The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …
Number of babies born with opioid dependence has tripled in US, says CDC report
August 12, 2016Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids
A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …
Allergan set to acquire eye-care biotech ForSight VISION5
August 12, 2016Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care
Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …
Novartis admits employees gave kickbacks to doctors in South Korea
August 12, 2016Medical Communications, Research and Development Novartis, kickbacks, south korea
Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …
Advaxis follows up Amgen deal with Phase IIa cancer trial success
August 12, 2016Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen
Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …
Gilead to work with Genmab on HIV targeting technology
August 12, 2016Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody
Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …
Thousands to benefit with new anti-clotting drug recommendation, says NICE
August 12, 2016Medical Communications, Sales and Marketing AstraZeneca, Brilique, ticagrelor
The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending AstraZeneca’s Brilique (ticagrelor) for people …
Valeant under criminal investigation
August 11, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation
Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …
FDA accepts Marathon’s Duchenne drug for priority review
August 11, 2016Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals
Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …
Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug
August 11, 2016Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol
Heron Therapeutics has announced that it has received US Food and Drug Administration (FDA) approval for Sustol (granisetron) for the …
Chronos Therapetics strengthens management with two new vice presidents
August 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …
New senior VP, finance at Eli Lilly
August 10, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly
Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
